Oncolytic Virotherapy of Neuroendocrine Neoplasms with the Vaccinia virus GLV-1h68 and the Herpes simplex virus T-VEC
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
Tübingen, Universität Tübingen, Dissertation, 2022
- Schlagwort
-
Tumors
Herpes simplex virus
Vaccinia
- Ereignis
-
Veröffentlichung
- (wo)
-
Tübingen
- (wer)
-
Universitätsbibliothek Tübingen
- (wann)
-
2022
- Urheber
- Beteiligte Personen und Organisationen
-
Lauer, Ulrich
- URN
-
urn:nbn:de:bsz:21-dspace-1251177
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
- 15.08.2025, 07:25 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Kloker, Linus Daniel
- Lauer, Ulrich
- Universitätsbibliothek Tübingen
Entstanden
- 2022
Ähnliche Objekte (12)
Oncolytic virotherapy and modulation of tumor microenvironment with vaccinia virus strains
Starvation-Induced Differential Virotherapy Using an Oncolytic Measles Vaccine and Vaccinia Virus
Vaccinia virus-encoded bacterial beta-glucuronidase as a diagnostic biomarker for oncolytic virotherapy
Vaccinia virus-encoded bacterial beta-glucuronidase as a diagnostic biomarker for oncolytic virotherapy
Comparative analysis of vaccinia virus encoded markers reflecting actual viral titres in oncolytic virotherapy
Comparative Analysis of Vaccinia Virus-Encoded Markers Reflecting Actual Viral Titres in Oncolytic Virotherapy
Oncolytic Virotherapy of Neuroendocrine Neoplasms with oncolytic measles vaccine virus
Oncolytic virotherapy and modulation of tumor microenvironment with vaccinia virus strains=Onkolytische Virotherapie und Modulation des Tumormilieus mittels verschiedener Vaccinia-Virus-Typen
Key parameters of measles virus production for oncolytic virotherapy
Effects of virus-induced immunogenic cues on oncolytic virotherapy
Targeting hematologic malignancies with oncolytic vaccinia virus constructs
Virotherapy of Canine Tumors with Oncolytic Vaccinia Virus GLV-1h109 Expressing an Anti-VEGF Single-Chain Antibody
Oncolytic virotherapy and modulation of tumor microenvironment with vaccinia virus strains
Starvation-Induced Differential Virotherapy Using an Oncolytic Measles Vaccine and Vaccinia Virus
Vaccinia virus-encoded bacterial beta-glucuronidase as a diagnostic biomarker for oncolytic virotherapy
Vaccinia virus-encoded bacterial beta-glucuronidase as a diagnostic biomarker for oncolytic virotherapy
Comparative analysis of vaccinia virus encoded markers reflecting actual viral titres in oncolytic virotherapy
Comparative Analysis of Vaccinia Virus-Encoded Markers Reflecting Actual Viral Titres in Oncolytic Virotherapy
Oncolytic Virotherapy of Neuroendocrine Neoplasms with oncolytic measles vaccine virus
Oncolytic virotherapy and modulation of tumor microenvironment with vaccinia virus strains=Onkolytische Virotherapie und Modulation des Tumormilieus mittels verschiedener Vaccinia-Virus-Typen
Key parameters of measles virus production for oncolytic virotherapy
Effects of virus-induced immunogenic cues on oncolytic virotherapy
Targeting hematologic malignancies with oncolytic vaccinia virus constructs
Virotherapy of Canine Tumors with Oncolytic Vaccinia Virus GLV-1h109 Expressing an Anti-VEGF Single-Chain Antibody
Oncolytic virotherapy and modulation of tumor microenvironment with vaccinia virus strains
Starvation-Induced Differential Virotherapy Using an Oncolytic Measles Vaccine and Vaccinia Virus
Vaccinia virus-encoded bacterial beta-glucuronidase as a diagnostic biomarker for oncolytic virotherapy
Vaccinia virus-encoded bacterial beta-glucuronidase as a diagnostic biomarker for oncolytic virotherapy
Comparative analysis of vaccinia virus encoded markers reflecting actual viral titres in oncolytic virotherapy
Comparative Analysis of Vaccinia Virus-Encoded Markers Reflecting Actual Viral Titres in Oncolytic Virotherapy
Oncolytic Virotherapy of Neuroendocrine Neoplasms with oncolytic measles vaccine virus
Oncolytic virotherapy and modulation of tumor microenvironment with vaccinia virus strains=Onkolytische Virotherapie und Modulation des Tumormilieus mittels verschiedener Vaccinia-Virus-Typen
Key parameters of measles virus production for oncolytic virotherapy
Effects of virus-induced immunogenic cues on oncolytic virotherapy
Targeting hematologic malignancies with oncolytic vaccinia virus constructs